Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September:

• Wells Fargo 2019 Healthcare Conference
  Presentation Date: Thursday, Sept 5^th at 10:55 a.m. Eastern Time
  Location: Boston, MA

• Morgan Stanley 17^th Annual Global Healthcare Conference
  Presentation Date: Monday, Sept 9^th at 8:10 a.m. Eastern Time
  Location: New York, NY

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.